Once a drug has been approved by the Federal Drug
Administration (FDA) as a result of clinical trials, practitioners
have the opportunity to offer feedback to the FDA
on any shortcomings in the use of the drug in clinical
practice. The Society of Clinical Psychology, Division 12 of
the American Psychological Association, is in the process of
establishing a mechanism whereby practicing psychotherapists
can report their clinical experiences using empirically
supported treatments (ESTs).